Current Status of COVID-19 Vaccines Rollout Nationwide: August 2021 Update for the Attorney General Community
On August 25, the U.S. reached over 363.9 million total COVID-19 vaccine doses administered with 202 million persons (60.9% of the total U.S. population) having received at least one dose and 171.2 million persons (51.6% of the total U.S. population) being fully vaccinated. Among those individuals aged 65 years and older, 91.5% have received at…
Current Status of COVID-19 Vaccines Rollout Nationwide: July 2021 Update for the Attorney General Community
On July 27, the U.S. reached over 342.2 million total COVID-19 vaccine doses administered with 188.7 million persons (56.8% of the total U.S. population) having received at least one dose and 163.2 million persons (49.1% of the total U.S. population) being fully vaccinated. Among those individuals aged 65 years and older, 89.5% have received at…
COVID-19 Credentials May Present Legal, Ethical, and Public Health Issues
On July 15, the U.S. reached over 336.1 million total doses administered with 185.1 million persons (55.8% of the total U.S. population) having received at least one dose and 160.4 million persons (48.3% of the total U.S. population) being fully vaccinated. Twenty states, the District of Columbia, Puerto Rico, and Guam have reached 70% or…
Current Status of COVID-19 Vaccines Rollout Nationwide: June 2021 Update for the Attorney General Community
In the U.S., the average daily rate of COVID-19 vaccines administered has decreased from a peak of 3.3 million on April 11 to around 1 million in June. On June 27, the U.S. reached over 323.3 million total doses administered with 179.3 million persons (54% of the total U.S. population) having received at least one…
Current Status of COVID-19 Vaccines Rollout Nationwide: May 2021 Update for the Attorney General Community
Here in the U.S., average daily rates of COVID-19 vaccines administered has decreased from a peak of 3.3 million on April 11 to 1.8 million in May. Approximately 1.3 million people per day are achieving fully vaccinated status (i.e., having received either both doses of Pfizer/BioNTech or Moderna vaccine or one dose of the Johnson…
Current Status of COVID-19 Vaccines Rollout Nationwide: April 2021 Update for the Attorney General Community
Here in the U.S., average daily rates of COVID-19 vaccines administered has increased from 2.5 million in March to a peak of 3+ million in April. On April 28, the U.S. reached over 234.6 million total doses administered with 98 million persons (29.5% of the total U.S. population) fully vaccinated (i.e., having received either both…
COVID-19 Vaccines and Effective Communications Strategies
The U.S. distribution of safe and efficacious vaccines to prevent COVID-19 has increased exponentially since December 2020. The average daily rates of vaccines administered in the U.S. has reached 3.3 million in April. On April 14, the U.S. reached more than 194.8 million total doses administered with 76.7 million persons (23.1% of the total U.S….
Current Status of COVID-19 Vaccines Rollout Nationwide: March 2021 Update for the Attorney General Community
The distribution of three safe and efficacious vaccines to prevent COVID-19 has continued to ramp up both globally and domestically. Here in the U.S., average daily rates of vaccines administered has increased from 1.5 million at the end of February to close to 2.5 million in March. On March 24, the U.S. reached over 130…
The Defense Production Act and Implications for the COVID-19 Vaccine Rollout
Since the U.S. Food and Drug Administration (FDA) issued authorizations for the Pfizer-BioNTech and Moderna vaccines to prevent COVID-19, millions of doses of both of these safe and effective vaccines have been administered throughout the United States. On February 27, the FDA authorized a third vaccine from Janssen, a subsidiary of Johnson & Johnson. An…
Current Status of COVID-19 Vaccines Rollout Nationwide: February 2021 Update for the Attorney General Community
In December 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech and Moderna vaccines to prevent COVID-19. Within twenty-four hours of each authorization, doses began shipping across the country to every state, marking significant milestones in the national response to the COVID-19 pandemic. Since then, over sixty-six million…
